Latest Stock Split Details
Key information about Apimeds Pharmaceuticals US, Inc's most recent stock split
Split Date: 2026-03-26
Split Ratio: 1:10
Price Before Split: $0.16
Price After Split: $0.02
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 10.00 times fewer shares (a 1:10 ratio)
- The price per share is increased proportionally
Historical Stock Splits
A comprehensive history of Apimeds Pharmaceuticals US, Inc's stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2026-03-26 | 1:10 | Yes | $0.16 | $0.02 |
About Apimeds Pharmaceuticals US, Inc
Company overview and industry information
Apimeds Pharmaceuticals US, Inc (APUS) operates in the Drug Manufacturers - Specialty & Generic industry. The recent 1-for-10 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.
Drug Manufacturers - Specialty & Generic
Go to Apimeds Pharmaceuticals US, Inc Summary